Innovent Biologics Inc IVBXF:OTCPK

*Data is delayed | Exchange | USD
Last | 05/03/24 EDT
5.42quote price arrow up+0.04 (+0.74%)
Volume
850
52 week range
3.55 - 6.41
Loading...
  • Open5.42
  • Day High5.42
  • Day Low5.42
  • Prev Close5.38
  • 52 Week High6.41
  • 52 Week High Date11/07/23
  • 52 Week Low3.55
  • 52 Week Low Date08/07/23

Key Stats

  • Market Cap8,118.88M
  • Shares Out1,622.68M
  • 10 Day Average Volume3,167.86
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change10.16

KEY STATS

  • Open5.42
  • Day High5.42
  • Day Low5.42
  • Prev Close5.38
  • 52 Week High6.41
  • 52 Week High Date11/07/23
  • 52 Week Low3.55
  • 52 Week Low Date08/07/23
  • Market Cap8,118.88M
  • Shares Out1,622.68M
  • 10 Day Average Volume3,167.86
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change10.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.09
  • P/E (TTM)-59.03
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Innovent Biologics Inc

 

Content From Our Affiliates

Profile

MORE
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical products, and provision of consultation and research and development services. The Company's main product is Tyvyt (sintilimab injection), which is used to treat relapsed or refractory classical Hodgkin’s lymphoma. The...
De-Chao Yu Ph.D.
Executive Chairman of the Board, Chief Executive Officer
You Fei
Chief Financial Officer
Address
168
Dongping Street, Suzhou Industrial Park
Suzhou, JNG
215123
China